Your browser doesn't support javascript.
loading
Plasma Endoglin is Associated with Favorable Outcome for Pemetrexed-Based Therapy in Advanced Non-Small Cell Lung Cancer.
Li, Che-Hsing; Ko, Jiunn-Liang; Hsiao, Yu-Ping; Tsai, Ming-Hung; Lai, Yen-Chein; Hsin, I-Lun; Kang, Yu-Ting; Sheu, Gwo-Tarng; Lin, Wea-Lung; Wu, Ming-Fang.
Affiliation
  • Li CH; Divisions of Medical Oncology and Pulmonary Medicine, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, 402, Taiwan.
  • Ko JL; Graduate Program in Immunology & Microbiology, Baylor College of Medicine, Houston, TX, 77030, USA.
  • Hsiao YP; Divisions of Medical Oncology and Pulmonary Medicine, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, 402, Taiwan.
  • Tsai MH; Institute of Medicine, Chung Shan Medical University, Taichung, 402, Taiwan.
  • Lai YC; CSMU Lung Cancer Research Center, Chung Shan Medical University, Taichung, 402, Taiwan.
  • Hsin IL; Division of Dermatology, Chung Shan Medical University Hospital, Taichung, 402, Taiwan.
  • Kang YT; School of Medicine, Chung Shan Medical University, Taichung, 402, Taiwan.
  • Sheu GT; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung, 40447, Taiwan.
  • Lin WL; Department of Medical Laboratory and Biotechnology, Chung Shan Medical University, Taichung, 402, Taiwan.
  • Wu MF; Institute of Medicine, Chung Shan Medical University, Taichung, 402, Taiwan.
Cancer Manag Res ; 13: 9305-9318, 2021.
Article in En | MEDLINE | ID: mdl-35221721

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Cancer Manag Res Year: 2021 Document type: Article Affiliation country: Taiwán

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Cancer Manag Res Year: 2021 Document type: Article Affiliation country: Taiwán